| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/30/2014 | CN101523215B 磁性和/或电子标签辅助检测系统和方法 Magnetic and / or secondary electronic tag detection system and method |
| 07/29/2014 | US8793078 Method for predicting activation energy using atomic fingerprint descriptor or atomic descriptor |
| 07/29/2014 | US8793076 Device for measuring the purity of ultrapure water |
| 07/29/2014 | US8792948 Optical sensor device and image processing unit for measuring chemical concentrations, chemical saturations and biophysical parameters |
| 07/29/2014 | US8792703 Method for tracking cells |
| 07/29/2014 | US8792095 Methods and apparatus for transport of airborne molecules using an active cyclical vapor/liquid exchange |
| 07/29/2014 | US8792089 Device for determining a concentration of a constituent of blood in a hose line |
| 07/29/2014 | US8791323 Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse |
| 07/29/2014 | US8791285 Activatable nanoprobes for intracellular drug delivery |
| 07/29/2014 | US8791258 Pro-fluorescent probes |
| 07/29/2014 | US8791238 Artificial binding proteins based on ubiquitin |
| 07/29/2014 | US8790934 Nanoparticles |
| 07/29/2014 | US8790933 Screening |
| 07/29/2014 | US8790929 Reagent for diluting blood sample and method for measuring mean corpuscular volume by using the same |
| 07/29/2014 | US8790895 Generation of artificial binding proteins on the basis of ubiquitin proteins |
| 07/29/2014 | US8790890 Diagnostic method for connective tissue and its application |
| 07/29/2014 | US8790885 Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same |
| 07/29/2014 | US8790884 Method for measuring sialic acid in immunoglobulin G and immunoglobulin G anti-double-stranded DNA antibodies |
| 07/29/2014 | US8790883 Methods of identifying NF-κB inhibitors |
| 07/29/2014 | US8790882 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/29/2014 | US8790881 Method for measuring IgG-mediated complement activation |
| 07/29/2014 | US8790880 Cysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficile |
| 07/29/2014 | US8790878 Diagnosis and treatment of breast cancer |
| 07/29/2014 | US8790872 Non-elispot assay |
| 07/29/2014 | US8790871 Detecting diastolic heart failure by protease and protease inhibitor plasma profiling |
| 07/29/2014 | US8790869 Renal cell carcinoma biomarkers |
| 07/29/2014 | US8790665 Serum protein-based detection of random sequence polymer compositions |
| 07/29/2014 | US8790651 Interleukin-31 monoclonal antibody |
| 07/29/2014 | US8790591 In vitro point-of-care sensor and method of use |
| 07/29/2014 | US8789410 Device for monitoring metal wires in a tire |
| 07/29/2014 | US8789405 Calibration method in measurement of hemoglobin A1c |
| 07/29/2014 | CA2718812C Porcine adenovirus type 3 genome |
| 07/29/2014 | CA2653761C Systems and methods for performing measurements of one or more materials |
| 07/29/2014 | CA2638973C Biosensor and method of making |
| 07/29/2014 | CA2621137C Biocompatible n,n-disubstituted sulfonamide-containing fluorescent dye labels |
| 07/29/2014 | CA2606136C Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test |
| 07/29/2014 | CA2592249C Binding proteins specific for human matriptase |
| 07/29/2014 | CA2589487C Means and methods for detecting methylated dna |
| 07/29/2014 | CA2576295C Microarray-mediated diagnosis of herpes virus infection by monitoring host's differential gene expression upon injection |
| 07/29/2014 | CA2542597C Meter and test sensor bank incorporating re-writable memory |
| 07/29/2014 | CA2483451C Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
| 07/29/2014 | CA2473289C Asymmetric urea compounds useful as naaladase and psma imaging agents |
| 07/29/2014 | CA2469015C Methods to view and analyze the results from diffraction-based diagnostics |
| 07/29/2014 | CA2411304C Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 07/24/2014 | WO2014113804A1 Anti-tnf and anti-il17 combination therapy biomarkers for inflammatory disease |
| 07/24/2014 | WO2014113785A1 Analytic device |
| 07/24/2014 | WO2014113770A1 Smartphone-based apparatus and method for obtaining repeatable, quantitative colorimetric measurement |
| 07/24/2014 | WO2014113736A1 Bioinformatics systems, apparatuses, and methods executed on an integrated circuit processing platform |
| 07/24/2014 | WO2014113723A1 Methods for diagnosing and treating sepsis |
| 07/24/2014 | WO2014113701A1 Evaluation, assays and treatment of pkal-mediated disorders |
| 07/24/2014 | WO2014113585A1 Split peroxidases and methods of use |
| 07/24/2014 | WO2014113567A2 Method and apparatus for analysis and selective catalytic reduction of nox-containing gas streams |
| 07/24/2014 | WO2014113558A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 07/24/2014 | WO2014113543A1 Continuous sonication for biotechnology applications and biofuel production |
| 07/24/2014 | WO2014113519A1 Using galectin-binding carbohydrates as predictors of melanoma progression and metastasis |
| 07/24/2014 | WO2014113449A1 Precious metals transaction systems and methods |
| 07/24/2014 | WO2014113433A1 Binding domain mapping |
| 07/24/2014 | WO2014113401A1 Automation tube positioning methodology |
| 07/24/2014 | WO2014113291A1 Method to identify patients that will likely respond to anti-tnf therapy |
| 07/24/2014 | WO2014113287A1 Open path gas detector |
| 07/24/2014 | WO2014113106A2 System and method for detecting liquid and aerosol forms of chemical analytes |
| 07/24/2014 | WO2014112974A1 Active control of thermal effects on optical computing devices |
| 07/24/2014 | WO2014111944A1 Systems and methods for identifying explosives |
| 07/24/2014 | WO2014111936A1 Methods and systems for identifying patient specific driver mutations |
| 07/24/2014 | WO2014111847A1 Method and apparatus for monitoring a level of a gaseous species of interest |
| 07/24/2014 | WO2014111710A1 Diagnosis of ulcerative colitis |
| 07/24/2014 | WO2014111580A1 Urolithin b for muscle growth |
| 07/24/2014 | WO2014111546A1 Method for the identification of bitter tasting compounds and bitter taste modulating compounds |
| 07/24/2014 | WO2014111521A1 Method for preparing an outer surface of a planar waveguide to be capable of binding target samples along a plurality of predetermined lines and a planar waveguide |
| 07/24/2014 | WO2014111456A1 Method to screen for the teratogenic potential of substances |
| 07/24/2014 | WO2014111443A1 Prediction of kidney disease progression using homoarginine as a biomarker |
| 07/24/2014 | WO2014111207A1 Diagnosis of leishmania infection |
| 07/24/2014 | WO2014110674A1 Biomarkers for rapid detection of an occurrence of a stroke event |
| 07/24/2014 | WO2014110628A1 Gene and mutations thereof associated with seizure disorders |
| 07/24/2014 | WO2014083427A3 Compositions and methods for detecting vitamin d |
| 07/24/2014 | WO2014082993A3 Molecular targets and compounds, and methods to identify the same, useful in the down-regulation of the th2 response |
| 07/24/2014 | WO2014074835A3 Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone |
| 07/24/2014 | WO2014072960A3 A method to identify and isolate pluripotent stem cells using endogenous blue fluorescence |
| 07/24/2014 | WO2014060894A3 Wide dynamic range fluid sensor based on nanowire platform |
| 07/24/2014 | WO2014052989A3 Methods, systems, and arrays for biomolecular analysis |
| 07/24/2014 | WO2013134743A9 Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof |
| 07/24/2014 | US20140207400 Method and Apparatus for Providing Data Processing and Control in a Medical Communication System |
| 07/24/2014 | US20140207388 Urine component analysis device and urine component analysis method |
| 07/24/2014 | US20140206961 Method and apparatus for in vivo collection of circulating biological components |
| 07/24/2014 | US20140206956 Device, system and method for in-vivo immunoassay |
| 07/24/2014 | US20140206931 Methods For Predicting Mammalian Embryo Viability |
| 07/24/2014 | US20140206872 Fluorescent dye |
| 07/24/2014 | US20140206848 Oligosaccharide modification and labeling of proteins |
| 07/24/2014 | US20140206847 Mutant protein capable of binding specifically and quickly to troponin i derived from human myocardium |
| 07/24/2014 | US20140206840 Fluorescent labeling of living cells |
| 07/24/2014 | US20140206822 Surface treatment method for magnetic particles, magnetic composite prepared thereby, and magnetic composite for labeling target materials |
| 07/24/2014 | US20140206776 MRM/SRM Assay for Death Receptor 5 Protein |
| 07/24/2014 | US20140206775 SRM/MRM Assay for the Fatty Acid Synthase Protein |
| 07/24/2014 | US20140206714 Lpa2 receptor-specific benzoic acid derivatives |
| 07/24/2014 | US20140206698 Methods of Diagnosing Diastolic Dysfunction |
| 07/24/2014 | US20140206636 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 07/24/2014 | US20140206632 Endothelin in the Diagnosis of Cardiac Disease |
| 07/24/2014 | US20140206628 Polypeptides for treating and/or limiting influenza infection |
| 07/24/2014 | US20140206623 Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients |
| 07/24/2014 | US20140206620 T cell receptors and related materials and methods of use |